A clinical and laboratory approach to the evaluation of innate immunity in pediatric CVID patients

Frontiers in Immunology

Volumn 6, Issue MAR, 2015, Pages

  Kutukculer, Necil ^a   Azarsiz, Elif ^a   Karaca, Neslihan E ^a   Ulusoy, Ezgi ^a   Koturoglu, Guldane ^a   Aksu, Güzide ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CD18 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BLOOD CELL COUNT; CELIAC DISEASE; CELL MIGRATION; CHEMOTAXIS; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INNATE IMMUNITY; LABORATORY DIAGNOSIS; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; MALE; MOLECULAR DIAGNOSIS; MONOCYTE; NATURAL KILLER T CELL; NEUTROPHIL; PHAGOCYTE; PHENOTYPE; PROTEIN EXPRESSION; RESPIRATORY BURST;

EID: 84926632143     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00145     Document Type: Article

References (34)

1. Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV: Common variable immunodeficiency: the immune system in chaos. Trends in molecular medicine. 2005; 11(8): 370-376.
2. Trujillo CM, Muskus C, Arango J, Patiño PJ, Montoya CJ: Quantitative and Functional Evaluation of innate immune responses in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011;21(3): 207-215.
3. Gougerot-Pocidalo MA, Elbim C, Dang PM, El Benna J: Primary immune deficiencies in neutrophil functioning. Presse Med 2006; 35: 871-8.
4. Dobmeyer TS, Raffel B, Dobmeyer JM, Findhammer S, Klein SA, Kabelitz D, Hoelzer D, Helm EB, Rossol R: Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur J Med Res 1995; 16: 9-15.
5. Nordøy I, Müller F, Aukrust P, Frøland SS: Adhesion molecules in common variable immunodeficiency (CVID)-a decrease in L-selectin positive T lymphocytes. Clin Exp Immunol 1998; 114: 258-63.
6. Aspalter RM, Sewell WA, Dolman K, Farrant J, Webster AD: Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia. Clin Exp Immunol 2000; 121: 506-14.
7. Eckert K, Schmitt M, Garbin F, Wahn U, Maurer HR: Tymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results. Int J Immunopharmacol 1994; 16: 1019-25.
8. Fulcher DA, Avery DT, Fewings NL, Berglund LJ, Wong S, Riminton DS, Adelstein S, Tangye S: Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency. Clin Exp Immunol 2009; 157: 365-9.
9. Carvalho KI, Karina M. Melo KM, Bruno FR, Snyder-Cappione JE, Nixon DF, Costa-Carvalho BT, Esper G. Kallas EG: Skewed Distribution of Circulating Activated Natural Killer T (NKT) Cells in Patients with Common Variable Immunodeficiency Disorders (CVID). PLoS One. 2010; 5: e12652.
10. Walker W, Aste-Amezega M, Kastelein RA, Trinchieri G, Hunter CA: IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-γ. J Immunol 1999; 162: 5894-5901.
11. North ME, Akbar AN, Borthwick N, Sagawa K, Funauchi M, Webster AD, Farrant J: Costimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency. Clin Exp Immunol 1994; 95: 204-8.
12. Arandi N, Mirshafiey A, Abolhassani H, Jeddi-Tehrani M, Edalat R, Sadeghi B, Shaghaghi M, Aghamohammadi A: Frequency and expression of inhibitory markers of CD4+CD25+FOXP3+ Regulatory T cells in patients with common variable immunodeficiency. Scand J Immunol 2013; 77: 405-12.
13. Conley M, Notarangelo LD, Etzioni A: Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiency). Clin Immunol 1999; 93: 190-7.
14. Rivoisy C, Gerard L, Boutboul D, malphettes M, Fieschi C, Durieu I, et al: Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency. J Clin Immunol 2012; 32: 98-105.
15. Aksu G, Genel F, Koturoglu G, Kurugol Z, Kutukculer N: Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr 2006; 48: 19-24.
16. Rudd CE, Taylor A, Schneider H: CD28 and CTLA-4 co-receptor expression and signal transduction. Immunol Rev 2009; 229: 12-26.
17. Lee, JA, Spidlen J, Boyce K, Cai J, Crosbies N, Dalphin M et al: MIFlowCyt: The Minimum Information about a Flow Cytometry Experiment. Cytometry A 2008; 73(10): 926-930.
18. Roederer M, Darzynkiewicz Z, Parks DR: Guidelines for the presentation of flow cytometric data. Methods Cell Biol 2004; 75: 241-56.
19. Alvarez DF, Helm K, Degregori J, Roederer M, Majka S: Publishing flow cytometry data. Am J Physiol Lung Cell Mol Physiol 2010; 298(2): 127-30.
20. Matsubara T, Anwar R, Fujiwara M, Ichiyama T, Furukawa S: CTLA-4 (CD152) expression in peripheral blood T cells in Kawasaki disease. Clin Exp Immunol. 2003; 132(1): 169-73.
21. Abolhassani H, Amirkashani D, Parvaneh N, Mohammadinejad P, Gharib B, Shahinpour S, Hirbod-Mobarakeh A, Mirghorbani M, Movahedi M, Gharagozlou M, Rezeai N, Aghamohammadi A: Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2013; 23: 323-29.
22. Kutukculer N, Gulez N, Karaca NE, Aksu G, Berdeli A: Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency. Clin Immunol. 2012; 32: 1165-79.
23. North ME, Webster ADB, Farrant J: Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma in CD28+ (cytotoxic) and CD28-(supressor) CD8+ subsets. Clin Exp Immunol 1998; 111: 70-75.
24. Ueda H, Howson JMM, Esposito L, Heward J, et al: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
25. Schubert D, Bode C, Kenefeck R, Hou TZ, Wing JB, Kennedy A, et al: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 2014; oct 20. doi: 10.1038/nm.3746.
26. Goodier MR, Londei M: CD28 is not directly involved in the response of human CD3-CD56+ natural killer cells to lipopolysaccharide: a role for T cells. Immunology 2004; 111: 384-90.
27. Ikinciogullari A, Dogu F, Babacan E, Oflaz G, Ertem U, Cavdar A: Natural killer cell numbers and cytotoxic activity in pediatric Hodgkin disease. Pediatric Hematology and Oncology 2000; 17: 133-39.
28. Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, et al: Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations. J Clin Invest 2002; 109: 1501-9.
29. Amoras AL, Kanegane H, Miyawaki T, Vilela MM: Defective Fc-, CR1-and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. J Investig Allergol Clin Immunol 2003; 13: 181-8.
30. Liu Y, Hanson S, Gurugama P, Jones A, Clark B, Ibrahim MAA: Novel NFKB2 mutation in early-onset CVID. J Clin Immunol 2014; 34: 686-90.
31. Badolato R: Leukocyte circulation: one-way or round-trip? Lessons from primary immunodeficiency patients. Journal of Leukocyte Biology 2004; 76: 1-6.
32. Jandus C, Boligan KF, Chijioke O et al. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest 2014; 124:1810-1820.
33. von Gunten S. Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations. Clinical & Experimental Immunology 2014; 178: 151-152.
34. Ballow M. The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol. 2011;127:315-323.